Skip to main content
TipRanks
Go Ultimate75% OFF

Andrew J.M Richards Insider Profile

4 Followers

Andrew J.M Richards, Director at Silence Therapeutics, holds 7.00K shares in Silence Therapeutics (Ticker: SLN), holds 7.00K shares in Silence Therapeutics (Ticker: GB:SLN), holds 76.10K shares in IXICO plc (Ticker: GB:IXI).

Andrew J.M Richards's Trading History

SLN
Silence Therapeutics
Jul 31, 2017―Informative Buy10.28K£37.45K
IXI
IXICO plc
Feb 04, 2016DirectorInformative Buy15.00K£9.70K
SUMM
Summit Therapeutics
Apr 05, 2012―Informative Buy6.00K£249.78K
VEC
Vectura
Mar 19, 2010―Uninformative Sell89.50K£552.08K
SLN
Silence Therapeutics
―Director―$138.60K

You May Also Like

Andrew J.M Richards insider profile FAQ

What is the percentage of profitable transactions made by Andrew J.M Richards?
The percentage of profitable transactions made by Andrew J.M Richards is 33%.
What is the average return per transaction made by Andrew J.M Richards?
The average return per transaction made by Andrew J.M Richards is -19.60%.
What stocks does Andrew J.M Richards hold?
Andrew J.M Richards holds: SLN, GB:IXI, GB:SLN, GB:SUMM, GB:VEC stocks.
What was Andrew J.M Richards's most profitable transaction?
Andrew J.M Richards’s most profitable transaction was an Informative Buy of GB:IXI stock on February 4, 2016. The return on the trade was 8.90%.
What is Andrew J.M Richards's role in Silence Therapeutics?
Andrew J.M Richards's role in Silence Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.